Çetin AYDIN, Mert GÖL, Ali BALOĞLU, Zerrin GEZGİN

Vulva kanseri nedeniyle radikal vulvektomi uygulanan hastaların değerlendirilmesi

Bu çalışmada kliniğimizde vulva kanseri tanısı alıp radikal vulvektomi yapılan 24 hastanın incelenmesi amaç edilmiştir. Olgular 1997 - 2001 tarihleri arasındaki 5 yıllık dönemden seçildi ve dosyaları retrospektif olarak incelendi. Hastalar özellikle yaş, başvuru şikayeti, tümörün lokalizasyonu, histopatolojik tip, uygulanan operasyon, operasyon sonrası komplikasyonlar, lenf nodu tutulumu ve bölgeleri açısından incelendi. Olguların büyük çoğunluğunda başvuru anında görülen en sık şikayet kaşıntı idi. Labium majus en sık tutulan lokalizasyondu. Tümörlerin boyuttan 0.5-5 cm. arasında değişmekteydi (ort: 2.7) idi. Squamöz hücreli kanser görülen tek histolojik tipdi. Tüm olgulara radikal vulvektomi uygulandı. Postoperatif 8. saatte, sadece 1 hasta pulmoner emboli nedeniyle kaybedildi. En sık görülen komplikasyonlar ise idrar yolu enfeksiyonu ve yara yeri açılmasıydı. Hastaların çoğunluğu evre 1B idi. Bir olguda pelvik lenf nodu (+) idi. Bir olgu tümör rekürrensi nedeniyle öldü.

Anahtar Kelimeler:

Vulva neoplazmları, Jinekolojik cerrahi prosedürler, Geriyedönük çalışma, Karsinom, yassı hücreli

Assessment of patients whom radical vulvectomy performed for vulvar carcinom

The aim of this study is to assess 24 patients who have diagnosed vulvar carcinom and performed radical vulvectomy in our clinic. Cases whom medical records reviewed retrospectively were selected in the 5 years period from 1997 through 2001. Patients were assessed especially for age, admission complaint, localization of the tumor, histopathologic type, the operation performed, complications after the operation, lymph node status and regions. The most common complaint of the patients in the admission was pruritus. Labium majus was the most common localization which was attacked. The size of the tumors varied between 0.5-5 cm. (mean:2.7). The only histopathologic type seen was squamoz cancer. Radical vulvectomy was performed to all patients. There was only one patient who died because of pulmonary embolus after 8 hours after the operation. The most common complications after the operation were wound dehissence and urinary tract infection. Most of the patients were in stage 1B. Pelvic lymph node was (+) only in one patient. One patient has been died because of the recurrence of the tumor.

Keywords:

Vulvar Neoplasms, Gynecologic Surgical Procedures, Retrospective Studies, Carcinoma, Squamous Cell,

PDF

___

1. Jaramillo BA. Malignant melanoma of the vulva. Obstet Gynecol 1985; 66:398.
2. Cavanagh D, Fiorica J, Hoffman M. Invasive carcinoma of vulva: Changing trends of in surgical management. Am J Obstet Gynecol 1990,163:1007.
3. Kohler U, Schone M, Pawlawitsch T. Results of an induvialized surgical therapy of vulvar carcinoma from 1973 - 1993. Zentrabl Gynakol 1997; 119:8-16.
4. Linde T, Operative Gynecology. Lippincot- Raven 1997; 1371-74.
5. Monk B, Burger R, Fritz L Prognostic significance of human papilloma virüs DNA in vulvar carcinoma. Obstet Gynecol 1995;85:709.
6. Jones R, Rowat D. Vulvar intraepithelial neoplasia: A clinical study of the outcome in 113 cases with relation to later development of invasive vulvar carcinoma. Obstet Gynecol 1994;84:741.
7. Abrao F, Boracat E, Marques A. Carcinoma of the vulva: Clinicopathologic factors involved in inguinal and pelvic lymph node metastasis. J Reprod Med 1990;35:1113.
8. Manahan K, Hudec J, Fanning J. Modified radical vulvectomy without lymphadenectomy under local anesthesia in medically compromised patient. Gynecol Oncol 1997;67(2):166-7.
9. Şiiler B, Alvarez R, Conner W, et al. Vaulvar cancer: a case control study of triple incision versus en block radical vulvectomy and inguinal lympadenectomy. Gynecol oncol 1995;57(3):335-9.
10. Lindert A, Symos E, Damen B, Heintz A: Wound healing after radical vulvectomy and inguino femoral lymphadenectomy: Experience with granolocyte colony stimulating factor. Euro J Obstet Gynecol Reprod Biol 1995;62(2):217-9.
11. Yii N, Niranjan N. Fetal flaps in vulvovaginal reconstruction. Br J Plast Surg 1996;49(8):547-54.
12. Berek J, Heaps J, Fu Y. Current cisplatin and 5-FU chemotherapy and extemal radiation for primary treatment of advanced stage squamous carcinoma of vulva. Gynecol Oncol 1991;40:171.
13. Keys H. Gynecologic Oncology Group randomized trials of combined technique therapy for vulvar cancer. Cancer 1993;71:1691.
14. Sebag D, Mclean C, Arnott S. Treatment of advanced carcinoma of the vulva with chemoradiotherapy: Can extensive surgery be avoided?. Int J Gynecol Cancer 1994;4:150.